Micropenis – Short Penis
“Short penis” or micropenis enhancement can be regarded as a cosmetic issue or as a functional goal, if applied criteria for clinically recognised cases of micropenis. In clinical language, “short penis” cases are more often referred as penile “dysmorphophobia” cases.
A “clinically relevant” short penis is definable as any length smaller than 1.6 inches (4 cm) for the flaccid penis and smaller than 2.75 inches (7 cm) for the erect or stretched penis. In these cases, penile enhancement is often sought after.
What people commonly have in mind when they think of a “short penis” might be different from real clinical cases of micropenis. Short penis or micropenis enhancement can be considered a functional goal if penis size falls below this defined measure.
Any man with a penis larger than 1.6 inches (4 cm) in flaccid state or 2.75 inches (7 cm) in erection state can consider themselves to have a penis big enough to perform. Nevertheless, the main aim of our medical enhancement devices and techniques is to increase their patients’ confidence and self-esteem regarding their sexual relations, not to increase the size and get a bigger size by itself.
Therefore, our medical extenders are useful for micropenis and short penis cases, but also for men who think that their sexual life would improve with this kind of medical devices (clinical studies).
Scientific studies support the safety and efficacy of using the Andropenis Mini extender in short penis cases as a feasible non-invasive, penile augmentation treatment, hence making it the first-line treatment option in men seeking penile lengthening.
Most clinically relevant “short penis” cases are due to low levels of testosterone, a growth hormone deficiency or by genetic syndromes. If this is the situation, consult a doctor in order to boost the potential and effective results of using our medical stretchers.
Enlargement of Penis in Patients With Hypogonadism Complex Approach to the Clinical Practice
10th Congress of the European Society for Sexual Medicine. November 25-28, 2007.
M.M. Sokolschik, R.Y. Petrovich, S.V. Gagarina, Ya.A. Vaziev, I.V. Sadakova
Conclusions: After penis enlargement many patients with hypogonadism had an improvement of the social and professional functioning level that reflected in the expansion of social contacts range on the basis of a rising self-rating. The results received after use of conservative penis enlargement allow us to judge the efficiency of hormone replacement therapy in combination with the Andropenis extender.
Testimony of professionals
BRITISH JOURNAL OF UROLOGY
A pilot phase-II prospective study to test the ‘efficacy’ and tolerability of a penile…
Study Made with:
Dr. Paolo Gontero
JOURNAL OF SEXUAL MEDICINE
Acute Phase Peyronie’s Disease Management with Traction Device…
Study made with:
العربية السعودية 4042-844-800
South Africa 0-800-980-322
General Disclaimer / FTC Disclosure: Results discussed on this website are understood to be “generally expected results” in compliance with all FTC requirements. Any extraordinary results experienced by any individual are specified according to the scientific study that endorses it explicitly. Results will vary with each individual. Statements on this website have not been evaluated by the Food and Drug Administration. Always read the product directions before use. As with other products, seek professional advice before using if you suffer material allergies and consult your doctor or pharmacist if you have an underlying medical condition or if on medication.